Defective apoptotic cell clearance in asthma and COPD--a new drug target for statins?

[1]  S. Hodge,et al.  Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. , 2007, American journal of respiratory cell and molecular biology.

[2]  G. Patti,et al.  Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. , 2007, The Annals of thoracic surgery.

[3]  Jai Youl Ro,et al.  Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. , 2007, European journal of pharmacology.

[4]  B. Lipworth,et al.  Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. , 2007, The Journal of allergy and clinical immunology.

[5]  A. Dirks,et al.  Statin-induced apoptosis and skeletal myopathy. , 2006, American journal of physiology. Cell physiology.

[6]  Yasushi Ito,et al.  Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin. , 2006, American journal of respiratory cell and molecular biology.

[7]  T. Omland,et al.  Statin use is associated with reduced mortality in COPD , 2006, European Respiratory Journal.

[8]  D. Bundschuh,et al.  Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors. , 2006, Pulmonary pharmacology & therapeutics.

[9]  Christopher Haslett,et al.  Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis , 2006, Nature Medicine.

[10]  J. Erjefält,et al.  Resolution of airway disease: removal of inflammatory cells through apoptosis, egression or both? , 2006, Trends in pharmacological sciences.

[11]  S. Hodge,et al.  Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages , 2006, European Respiratory Journal.

[12]  Dmitri V. Krysko,et al.  Clearance of apoptotic and necrotic cells and its immunological consequences , 2006, Apoptosis.

[13]  N. Thomson,et al.  Potential therapeutic role for statins in respiratory disease , 2006, Thorax.

[14]  M. Etminan,et al.  Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. , 2006, Journal of the American College of Cardiology.

[15]  R. Bowler,et al.  Lovastatin Enhances Clearance of Apoptotic Cells (Efferocytosis) with Implications for Chronic Obstructive Pulmonary Disease1 , 2006, The Journal of Immunology.

[16]  I. Douglas,et al.  Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. , 2006, Chest.

[17]  P. Henson,et al.  Recognition ligands on apoptotic cells: a perspective , 2006, Journal of leukocyte biology.

[18]  T. Shim,et al.  Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. , 2005, American journal of respiratory and critical care medicine.

[19]  S. Wenzel,et al.  Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages. , 2005, American journal of respiratory and critical care medicine.

[20]  D. Sexton,et al.  Control of eosinophil toxicity in the lung. , 2005, Current drug targets. Inflammation and allergy.

[21]  D. Sexton,et al.  Airway inflammation resolution , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  C. Haslett,et al.  Kinetics of pulmonary neutrophil recruitment and clearance in a natural and spontaneously resolving model of airway inflammation , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[23]  R. A. Ezekowitz,et al.  Phagocytosis: elegant complexity. , 2005, Immunity.

[24]  A. Agustí,et al.  Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD , 2005, European Respiratory Journal.

[25]  S. Hodge,et al.  Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation , 2005, European Respiratory Journal.

[26]  M. Ehrenstein,et al.  Atorvastatin Inhibits Autoreactive B Cell Activation and Delays Lupus Development in New Zealand Black/White F1 Mice1 , 2004, The Journal of Immunology.

[27]  G. Walsh,et al.  Phagocytosis of apoptotic eosinophils but not neutrophils by bronchial epithelial cells , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[28]  N. Thomson,et al.  A Novel Anti-Inflammatory Role of Simvastatin in a Murine Model of Allergic Asthma1 , 2004, The Journal of Immunology.

[29]  K. Aoshiba,et al.  Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. , 2004, Chest.

[30]  K. Chida,et al.  Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages. , 2004, American journal of respiratory and critical care medicine.

[31]  Isabelle Vachier,et al.  Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. , 2003, American journal of respiratory and critical care medicine.

[32]  G. Walsh,et al.  Reduced eosinophil apoptosis in induced sputum correlates with asthma severity , 2003, European Respiratory Journal.

[33]  S. Hodge,et al.  Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells , 2003, Immunology and cell biology.

[34]  C. Haslett,et al.  Inhibition of nuclear factor‐κB activation un‐masks the ability of TNF‐α to induce human eosinophil apoptosis , 2002 .

[35]  D. Sexton,et al.  Human alveolar epithelial cells engulf apoptotic eosinophils by means of integrin- and phosphatidylserine receptor-dependent mechanisms: a process upregulated by dexamethasone. , 2001, The Journal of allergy and clinical immunology.

[36]  C. Brambilla,et al.  Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study , 2001, The Lancet.

[37]  F. Levi-Schaffer,et al.  Mechanism of tumour necrosis factor alpha mediated eosinophil survival. , 2001, Cytokine.

[38]  P. Barnes,et al.  New drugs for asthma, allergy and COPD , 2001 .

[39]  J. D’Armiento,et al.  Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. , 2001, American journal of respiratory and critical care medicine.

[40]  D A Lynch,et al.  Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. , 2001, American journal of respiratory and critical care medicine.

[41]  S. Pierce,et al.  Floating the Raft Hypothesis for Immune Receptors: Access to Rafts Controls Receptor Signaling and Trafficking , 2001, Traffic.

[42]  P. Hirth,et al.  Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.

[43]  John Savill,et al.  Corpse clearance defines the meaning of cell death , 2000, Nature.

[44]  D. Sexton,et al.  Resting and cytokine-stimulated human small airway epithelial cells recognize and engulf apoptotic eosinophils. , 1999, Blood.

[45]  A. J. Wilson,et al.  Eosinophil apoptosis and the resolution of airway inflammation in asthma. , 1996, American journal of respiratory and critical care medicine.

[46]  I. Rahman,et al.  Hypoxia prolongs neutrophil survival in vitro , 1995, FEBS letters.

[47]  R. Voll,et al.  Inefficient clearance of dying cells and autoreactivity. , 2006, Current topics in microbiology and immunology.

[48]  C. Haslett,et al.  MECHANISMS OF STEROID ACTION AND RESISTANCE IN INFLAMMATION Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation , 2003 .